Nicole Pinto

2PUBLICATIONS
4CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 13, 2018
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models.

Nicole Pinto, Stephenie D Prokopec, Frederick Vizeacoumar

|Oct 03, 2014
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer.

Nicole Pinto, Morgan Black, Krupal Patel

Pageof 1

Frequent Collaborators

1 joint publications

Morgan Black

1 joint publications

John Yoo

1 joint publications

Matthew Lowerison

1 joint publications

Paul C Boutros